Related Experiment Video
Updated: Oct 6, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design.
Daisuke Chujo1,2,3, Akihisa Imagawa4, Kazuki Yasuda5
1Department of Diabetes, Endocrinology, and Metabolism, National Center for Global Health and Medicine, 1-21-1, Toyama, Shinjuku, Tokyo, 162-8655 Japan.
This study establishes the Japanese Type 1 Diabetes Database Study (TIDE-J), a prospective registry for type 1 diabetes (T1D) subtypes. TIDE-J aims to clarify distinct clinical courses and identify biomarkers for T1D subtyping and outcomes.
Area of Science:
- Endocrinology and Metabolism
- Immunology
- Genetics
Background:
- Type 1 diabetes (T1D) exhibits heterogeneity, classified into acute-onset, slowly progressive, and fulminant subtypes in Japan.
- Existing cross-sectional databases lack prospective longitudinal data for investigating T1D clinical outcomes in Japan.
Purpose of the Study:
- To construct a multi-center prospective longitudinal database for the three T1D subtypes in Japan, incorporating genetic information and biobanking.
- To facilitate the understanding of distinct clinical courses among T1D subtypes.
- To identify novel diagnostic markers and predict clinical outcomes, including beta-cell function and disease severity.
Main Methods:
- The Japanese Type 1 Diabetes Database Study (TIDE-J) was established, enrolling patients with T1D duration <5 years, positive islet autoantibodies or low C-peptide, and ability to consent.
- Annual collection of clinical data (glycemic control, insulin secretion, autoantibodies, complications, treatment) via REDCap.
- HLA genotyping at entry and annual storage of blood samples for exploratory and genetic analyses.
Main Results:
- The TIDE-J database construction is complete, enabling longitudinal tracking of T1D subtypes.
- Data collection infrastructure is in place for comprehensive annual assessments.
- Genetic and biobanking components are integrated for future biomarker discovery.
Conclusions:
- The TIDE-J database provides a crucial resource for understanding the heterogeneity of T1D in Japan.
- This resource is expected to reveal distinct clinical trajectories for each T1D subtype.
- Future analyses may lead to improved diagnostic tools and personalized treatment strategies for T1D.
Related Concept Videos
Study Designs in Epidemiology
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Study Design in Statistics
Does aspirin reduce the risk of heart attacks? Is one brand of fertilizer more effective at growing roses than another? Is fatigue as dangerous to a driver as the influence of alcohol? Questions like these are answered using randomized experiments with proper...
Bioavailability Study Design: Healthy Subjects Versus Patients
Diabetes Mellitus: Type 2 and Gestational
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

